Fused heterocyclic derivatives and methods of use

Details for Australian Patent Application No. 2007272783 (hide)

Owner Amgen Inc.

Inventors Boezio, Alessandro; Springer, Stephanie; Booker, Shon; Xi, Ning; Liu, Longbin; Potashman, Michele; Kim, Tae-Seong; Lohman, Julia; D'amico, Derin; Bauer, David; Norman, Mark; Yang, Kevin; Siegmund, Aaron; Stec, Markian; Albrecht, Brian; Harmange, Jean-Christophe; Lewis, Richard; Choquette, Deborah; Hungate, Randall; Bellon, Steven; Bode, Christiane; Hirai, Satoko

Agent Shelston IP

Pub. Number AU-B-2007272783

PCT Pub. Number WO2008/008539

Priority 60/830,882 14.07.06 US

Filing date 13 July 2007

Wipo publication date 17 January 2008

Acceptance publication date 26 April 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 473/34 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/008539 Priority application(s): WO2008/008539

5 February 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name Amgen Inc., Application No. 2007272783, under INID (54) correct the title to read Fused heterocyclic derivatives and methods of use

26 April 2012 Application Accepted

  Published as AU-B-2007272783

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272785-Methods to elicit, enhance and sustain immune responses against MHC class1 restricted epitopes, for prophylactic or therapeutic purposes

2007272781-Combi) compositions for the treatment of mucormycosis. comprising iron chelator and antifungal agent